Malta Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Lenalidomide and Low-dose Cyclophosphamide for MALT Lymphoma
Conditions:   Antibiotics-unresponsive MALT Lymphoma;   Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma;   Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT) Intervention:   Drug: Lenalidomide [Leavdo®] Sponsor:   National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2020 Category: Research Source Type: clinical trials